A Comparative Study of EMG Biofeedback and Pharmacotherapy for the Treatment of Masticatory Muscle Hyperactivity in Bruxism Patients

NANot yet recruitingINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

March 26, 2025

Primary Completion Date

April 26, 2025

Study Completion Date

May 1, 2025

Conditions
Bruxism
Interventions
OTHER

Electromyography biofeedback

Participants in the experimental group will receive surface electromyography (SEMG) feedback training, targeting the Masseter muscle, for 40 minutes per session according to the Evidence-Based practice since longer practice may become counterproductive due to fatigue and loss of focus. The frequency of the sessions will be 3 sessions/week for 4 weeks.

DRUG

Pharmacotherapy

Pharmacotherapy will be received by all participants in the two groups in the form of multi relaxant (cyclobenzaprine) 10 MG twice daily for 4 weeks \& anti inflammatory (non steroidal anti-inflammatory drugs).

Trial Locations (1)

Unknown

Misr University for Science and Technology, Giza

All Listed Sponsors
lead

Beni-Suef University

OTHER

NCT06894472 - A Comparative Study of EMG Biofeedback and Pharmacotherapy for the Treatment of Masticatory Muscle Hyperactivity in Bruxism Patients | Biotech Hunter | Biotech Hunter